45P：延长随访证实了单药治疗PD-L1高表达的晚期非小细胞肺癌（NSCLC）的实际疗效和安全性

IF 21 1区医学 Q1 ONCOLOGY

Journal of Thoracic Oncology Pub Date : 2025-03-01 DOI:10.1016/S1556-0864(25)00240-0

S. Masini , R. Alvarez Cabellos , I. De Elejoste Echebarria , M. Martinez Kareaga , M. Antonanzas Basa , M.C. Escoin Perez , F. Navarro , C. Traseira Puchol , L. Cabezon Gutierrez , S. Falagán Martínez , C. Garcia Benito , L. Masfarre Pinto , C. Avila Andrade , S. Sequero , J. Mosquera Martinez , E. Garcia Lorenzo , A. Azkárate Martínez , L. Paz-Ares , J. Zugazagoitia , J. Baena Espinar

{"title":"45P：延长随访证实了单药治疗PD-L1高表达的晚期非小细胞肺癌（NSCLC）的实际疗效和安全性","authors":"S. Masini , R. Alvarez Cabellos , I. De Elejoste Echebarria , M. Martinez Kareaga , M. Antonanzas Basa , M.C. Escoin Perez , F. Navarro , C. Traseira Puchol , L. Cabezon Gutierrez , S. Falagán Martínez , C. Garcia Benito , L. Masfarre Pinto , C. Avila Andrade , S. Sequero , J. Mosquera Martinez , E. Garcia Lorenzo , A. Azkárate Martínez , L. Paz-Ares , J. Zugazagoitia , J. Baena Espinar","doi":"10.1016/S1556-0864(25)00240-0","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Pages S39-S40"},"PeriodicalIF":21.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"45P: Extended follow-up confirmed real-world efficacy and safety of cemiplimab monotherapy in advanced non-small cell lung cancer (NSCLC) with high PD-L1 expression\",\"authors\":\"S. Masini , R. Alvarez Cabellos , I. De Elejoste Echebarria , M. Martinez Kareaga , M. Antonanzas Basa , M.C. Escoin Perez , F. Navarro , C. Traseira Puchol , L. Cabezon Gutierrez , S. Falagán Martínez , C. Garcia Benito , L. Masfarre Pinto , C. Avila Andrade , S. Sequero , J. Mosquera Martinez , E. Garcia Lorenzo , A. Azkárate Martínez , L. Paz-Ares , J. Zugazagoitia , J. Baena Espinar\",\"doi\":\"10.1016/S1556-0864(25)00240-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17515,\"journal\":{\"name\":\"Journal of Thoracic Oncology\",\"volume\":\"20 3\",\"pages\":\"Pages S39-S40\"},\"PeriodicalIF\":21.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Thoracic Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1556086425002400\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1556086425002400","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

45P: Extended follow-up confirmed real-world efficacy and safety of cemiplimab monotherapy in advanced non-small cell lung cancer (NSCLC) with high PD-L1 expression

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Thoracic Oncology 医学-呼吸系统

CiteScore

36.00

自引率

3.90%

发文量

1406

审稿时长

13 days

期刊介绍： Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer,is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies.The readship includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.